Creso Pharma Limited Stock News

Shares of Melodiol Global Health Limited (OTCMKTS:COPHF – Free Report) are set to reverse split before the market opens on Wednesday, June 5th. The 1-30 reverse split was announced on Wednesday,

The Secure and Fair Enforcement (SAFE) Banking Act made headlines again this week as it was the focus of a Senate committee hearing on marijuana banking challenges.  Typically any progress on this 

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) (Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF), Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)) subsidiary Halucenex Life Sciences Inc will expand the scope of Phase 2 clin

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian-based psychedelics subsidiary Halucenex Life Sciences Inc. has been included on a list of companies that can provide psychedelic compo

Cannabis company Creso Pharma Limited (ASX: CPH) (OTC: COPHF) (FRA:1X8) is entering the US CBD market, following a purchase agreement to acquire Colorado-based consumer packaged goods company, Sierra

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has entered the US CBD market. The company has executed a Membership Interest Purchase Agreement to acquire Colorado-based consumer packaged goods company, Sier

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) psychedelics subsidiary Halucenex Life Sciences Inc has lodged a Clinical Trial Authorisation (CTA) with Health Canada for a planned phase II clinical trial

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has launched the next stage of its growth strategy, appointing executives with strong backgrounds in the lucrative cannabis market. In a push to strengthen its

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) subsidiary Halucenex Life Sciences Inc has been invited by Health Canada to become a potential supplier of psychedelics like psilocybin under the new Special A

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian subsidiary Mernova Medicinal Inc. has generated A$666,042 (C$612,734) in revenue during the current quarter, adding to the total of A$3

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian-based psychedelics company, Halucenex Life Sciences Inc. has secured an upgrade to its Controlled Drugs and Substances Dealer's Licence

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has completed the integration of Creso ImpACTIVE Ltd's assets into its product portfolio in a move that should help CPH increase its North American footprint a

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s Swiss operations have generated revenue of A$817,429 (CHF 552,548) in Q4 2021 – a 126% increase on the division's revenue over last quarter of A$362,448. Th

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian-based psychedelics company, Halucenex Life Sciences Inc. has received results described as "exceptional" from laboratory testing initia

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has appointed Dr Brian Walker as a strategic consultant to increase its R&D and management capacity. His appointment is expected to produce benefits across all